[HTML][HTML] Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea

…, F Mentre, X Anglaret, D Malvy, JIKI Study Group - PLoS …, 2016 - journals.plos.org
… the safety and efficacy of favipiravir in patients with EVD, the … emergency trial in the context
of a large Ebola outbreak and to … effectiveness of favipiravir in reducing mortality and viral load …

[HTML][HTML] Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

M Lipsitch, D Sissoko, C Laouenan, E Folkesson… - PLoS …, 2016 - dial.uclouvain.be
trial, in which all patients would receive favipiravir along with standardized care. The objectives
of the trial … of an emergency trial in the context of a large Ebola outbreak, and to collect …

Experimental therapies for Ebola virus disease: what have we learned?

FG Hayden, M Friede, DG Bausch - … of infectious diseases, 2017 - academic.oup.com
… No apparent survival benefit as compared to historical … of conducting trials in Ebola treatment
units during an outbreak … studies on the treatment of influenza with favipiravir, which was …

Laboratory findings, compassionate use of favipiravir, and outcome in patients with Ebola virus disease, Guinea, 2015—a retrospective observational study

R Kerber, E Lorenz, S Duraffour… - … infectious diseases, 2019 - academic.oup.com
… including the broad-spectrum antiviral drug favipiravir, monoclonal antibody cocktails, small
… 2016 EVD outbreak [16–19]. After completion of the JIKI clinical trial for favipiravir in Guinea […

Editorial Commentary: Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus Disease

CS Kraft - Clinical Infectious Diseases, 2016 - academic.oup.com
… heels of the JIKI trial, which was a historically controlled, single-arm, proof-of-concept trial
in Guinea. The outcome from this study of 111 patients was that favipiravir monotherapy may …

Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials

V Madelain, F Mentré, S Baize… - CPT …, 2020 - Wiley Online Library
experiments and expected in the JIKI trial. Accordingly, a first … In addition to historical
preclinical data available from the … Ebola virus and treated with ascending doses of favipiravir. Left…

[HTML][HTML] Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted

…, F Mentré, JIKI Study Group - … tropical diseases, 2017 - journals.plos.org
favipiravir tolerance and efficacy in patients with Ebola virus (… tolerance and efficacy in
patients with Ebola virus disease (… a historically-controlled, single-arm proof-of-concept trial to …

Clinical evaluation of Ebola virus disease therapeutics

G Liu, G Wong, S Su, Y Bi, F Plummer, GF Gao… - Trends in molecular …, 2017 - cell.com
… Full, or interim results of clinical trials for a number of experimental therapeutics have recently
Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically

[HTML][HTML] Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques

J Guedj, G Piorkowski, F Jacquot, V Madelain… - PLoS …, 2018 - journals.plos.org
… The historically controlled, single-arm proof-of-concept JIKI … successive experiments with
increasing doses of favipiravir … patients treated with oral 1,200 mg BID favipiravir (JIKI trial), …

[HTML][HTML] The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers

D Malvy, AM Taburet, X de Lamballerie… - … Tropical Diseases, 2020 - journals.plos.org
treating influenza virus infections. In the setting of the pioneer Phase II JIKI trial, 126 patients
with acute Ebola virus diseaseJIKI trial, favipiravir treatment was offered in the Coyah Ebola